Skip to content
Research/Mitochondrial Health/Photobiomodulation

Photobiomodulation

Photobiomodulation (PBM) is a therapy that uses specific wavelengths of light to penetrate tissues and stimulate cellular processes, particularly within the mitochondria. This can enhance cellular energy production, reduce inflammation, and promote tissue repair, making it relevant for longevity and health optimization.

Intelligence Profile

Clinical Applications

Photobiomodulation (PBM) is being explored for a variety of clinical applications, supported by emerging research and trials.

  1. Chronic Pain Management: A protocol for a multicenter, randomized, triple-blind, placebo-controlled trial is examining PBM combined with a static magnetic field for managing chronic non-specific knee pain. This study could clarify PBM’s role in pain reduction and functional improvement for knee pain sufferers.

  2. Oral Health and Surgery: PBM is being investigated for its potential in dental and oral surgery contexts. A study evaluated its effects on autogenous bone graft success in patients with cleft lip and palate, while another systematic review analyzed its efficacy in treating oral lichen planus, showing promise as an adjunctive treatment.

  3. Orthodontics and Periodontics: PBM’s impact on the plaque microbiome in patients undergoing periodontal and orthodontic treatments is under investigation, indicating a potential role in maintaining oral health during orthodontic retention.

  4. Ophthalmology and Myopia Control: Multiple studies are assessing PBM’s effects on eye health, including repeated low-level red-light therapy for controlling myopia progression. Trials emphasize its safety and potential to slow myopia in children and adolescents.

  5. Neurological Applications: Clinical trials are recruiting to evaluate PBM's effects on brain connectivity and cognitive function in individuals with cognitive impairment, as well as its potential benefits for autism spectrum disorders through non-invasive near-infrared light stimulation.

  6. Inflammation and Immune Response: Research involving PBM combined with dexamethasone investigated the therapy’s influence on cellular metabolic activity and inflammation in activated macrophages, pointing to possible anti-inflammatory benefits.

  7. Chemotherapy-induced Alopecia: A completed study looked at home-use, low-level light therapy helmet devices for reducing hair loss caused by chemotherapy, exploring PBM’s role in supportive cancer care.

While these studies suggest a wide range of potential applications, further rigorous trials are necessary to establish PBM's effectiveness and long-term safety across these contexts. Current research remains exploratory, with many trials still in progress.

Disclaimer: This summary is for informational purposes only and should not be used for medical diagnosis or treatment. Please consult healthcare professionals for medical advice.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.